Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;12(4):593-601.
doi: 10.1007/s11481-017-9752-7. Epub 2017 May 29.

Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition

Affiliations
Review

Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition

Marina Bogush et al. J Neuroimmune Pharmacol. 2017 Dec.

Abstract

Diabetes mellitus (DM) is a disorder due to the inability properly to metabolize glucose associated with dysregulation of metabolic pathways of lipids and proteins resulting in structural and functional changes of various organ systems. DM has detrimental effects on the vasculature, resulting in the development of various cardiovascular diseases and stemming from microvascular injury. The blood brain barrier (BBB) is a highly specialized structure protecting the unique microenvironment of the brain. Endothelial cells, connected by junctional complexes and expressing numerous transporters, constitute the main cell type in the BBB. Other components, including pericytes, basement membrane, astrocytes and perivascular macrophages, join endothelial cells to form the neurovascular unit (NVU) and contribute to the proper function and integrity of the BBB. The role of the BBB in the pathogenesis of diabetic encephalopathy and other diabetes-related complications in the central nervous system is apparent. However, the mechanisms, timing and consequences of BBB injury in diabetes are not well understood. The importance of further studies related to barrier dysfunction in diabetes is dictated by its potential involvement in the cognitive demise associated with DM. This review summarizes the impact of DM on BBB/NVU integrity and function leading to neurological and cognitive complications.

Keywords: Blood brain barrier; Cognitive impairment; Diabetes; Endothelial cell; Neuroinflammation; Pericyte.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structural adaptations of the BBB to prolonged hyperglycemia. (A) Components of the BBB under normal physiological conditions. The vessel lumen (red) is enclosed by endothelial cells (blue), which attenuate paracellular transport via TJs. A basement membrane (light green) encloses these components and encases pericytes (orange) associated with the vessel. Astrocytic end feet (green) surround the basement membrane, providing an additional barrier to brain parenchyma access (light blue). (B) Pathologic changes to the BBB following prolonged exposure to hyperglycemia. Capillary density is increased as a result of sprouting from existing microvasculature. The basement membrane exhibits thickening and barrier integrity is decreased, in part due to TJ alteration and increased paracellular diffusion. Lastly, pericytes associated with the vessel undergo degeneration, leading to ‘acellular capillary’ appearance histologically.
Figure 2
Figure 2
Impact of AGEs on cellular components of the BBB in vitro. Shimizu et al. (2013) demonstrated that AGEs may stimulate the production of fibronectin through RAGE and TGF-β, presumably leading to BM thickening. Additionally, claudin-5 expression is reduced in endothelial cells exposed to AGEs, which act through RAGE, VEGF, and MMP-2. Caudin-5 is also reduced by TGF-β exposure, suggesting that pericytes may modulate claudin-5 through this mediator (Shimizu et al., 2013). Given that VEGF, TGF-β, and MMP-2 are secreted proteins, it is assumed that VEGF and TGF-β act in an autocrine/paracrine manner while MMP-2 exerts its enzymatic action extracellularly.

References

    1. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000;20:131–147. - PMC - PubMed
    1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13–25. - PubMed
    1. Acharya NK, Levin EC, Clifford PM, Han M, Tourtellotte R, Chamberlain D, Pollaro M, Coretti NJ, Kosciuk MC, Nagele EP, Demarshall C, Freeman T, Shi Y, Guan C, Macphee CH, Wilensky RL, Nagele RG. Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib. J Alzheimers Dis. 2013;35:179–198. - PubMed
    1. Ahmed N. Advanced glycation endproducts--role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005;67:3–21. - PubMed
    1. Alexandru N, Badila E, Weiss E, Cochior D, Stepien E, Georgescu A. Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players. Biochem Biophys Res Commun. 2016;472:1–10. - PubMed